Friday, December 25, 2015

Year In Review: 2015

The latest news from Doctor's Choice!
View this email in your browser

Year in Review

It is hard to believe that another year is almost done. For Life Choice, the year 2015 was an exciting and rewarding year. We anticipate the year 2016 to be just as productive and just as rewarding. In general, 2015 was quite the year for Life Choice.

During the year we touched on many different health related topics: Alzheimer's, dementia, autism, cerebral palsy, weight loss, obesity, type 2 diabetes, ADHD, dyslexia, osteoporosis, calcium deficiency, digestion disorders, cancer, heart disease, respiratory illness, anxiety, stress, suicidal thoughts, arthritis, addictions, environmental toxicity - to name only a few.

Between our newsletters and regular webinars, we sought to provide information that would be relevant to our customers and their clients.

It was also a year that saw Life Choice introduce two new products to the Life Choice family: Full Spectrum Digestive Enzyme and Active Woman.

Life Choice also launched brand new websites: lifechoice.net, retail.lifechoice.net (for international customers), and doctorschoice.ca

However, the highlight of the year was early in 2015 when Life Choice products were included in the 2015 Academy Awards Swagbag -  an item that is given to all nominees and non winners of the 87th Oscars - Life Choice contributions were very well received and highly valued by the Swagbag recipients.

Our industry also faced challenges in 2015, such as the negative press from the CBC Market Place and the 5th Estate. The weak Canadian dollar is another looming challenge we must meet, since most goods are traded in US currency. Our USP pharmaceutical grade raw materials will be more challenging to purchase; however, we have no intention of compromising product quality for convenience.

All in all, 2015 was a very productive year for the Life Choice family of professional, therapeutic medicines. We anticipate 2016 to be just as rewarding. Why? Because we know that our high quality, professional, therapeutic medicines have been researched and formulated to give you the health benefits that you demand and deserve!

On behalf of the staff of Life Choice we wish you all the best for 2016 and we wish you and your family the best for this upcoming holiday season.

Happy Holidays and best wishes for 2016.


 

View the December 10 Webinar!

December 10 Webinar: Link
All Webinars: Link




 



Bio:
Eldon Dahl, Founder, Chief Executive Officer of Life Choice Ltd. Eldon has nearly three decades of experience in the naturopathic and natural healing industries. In his executive role with the company, Eldon oversees all daily operations, he also spearheads all health research into medical conditions—specifically anti-aging and chronic disease treatments.

Eldon graduated with a Doctorate of Naturopathic medicine in 1988, he entered the field after witnessing family members struggle with cancer and recognizing a connection between nutrition and disease. He attributes his success in the industry by not compromising on core values, and using the highest quality raw materials in all formulations. His mission statement of “Healing the Nation, One Person at a Time” really says it all.

Outside of his work with Life Choice, Eldon gives back to the community through his volunteer efforts offering free supplements to naturopathic satellite clinics.
Facebook
Facebook
Website
Website
Twitter
Twitter

With over 10 years of experience, Bond Consulting is a leader in the SR&ED industry. The SR&ED program is designed to support innovative companies with cash reimbursements from the Canadian Government due to their private R&D efforts. (www.bondconsulting.ca)





Copyright © *|2015|* *|Doctor's Choice TM|*, All rights reserved.


Our Contact Info is:
Address: P.O. Box 1696 Station Main, Cochrane, AB T4C 1B6
Tel: 866-226-1722
Fax: 866-226-1822
E-mail: info@doctorschoice.ca
Web: www.doctorschoice.ca

unsubscribe from this list    update subscription preferences 






























































































No comments:

Post a Comment